Endoscopic retrograde cholangiopancreatography is a radiologic imaging technique, which is performed by combining both endoscopy and fluoroscopy for the treatment of biliary disorders.
Scope of the Report:
This report studies the Endoscopic Retrograde Cholangiopancreatography market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Endoscopic Retrograde Cholangiopancreatography market by product type and applications/end industries.
This technique is majorly utilized for the diagnosis of certain disorders associated with pancreatic ductal systems.
Moreover, it assists in the detection of aberrations in the common bile duct, cystic duct, hepatic ducts, and pancreatic ducts.
The global Endoscopic Retrograde Cholangiopancreatography market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Endoscopic Retrograde Cholangiopancreatography.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson
Boston Scientific Corporation
Medtronic
CONMED
Stryker
Fujifilm
Ethicon
Becton Dickinson
B.Braun Melsungen
Cook Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Endoscopic sphincterotomy
Removal of stones or other biliary debris
Insertion of bile duct stent(s)
Dilation of strictures
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Endoscopic Retrograde Cholangiopancreatography Market Overview
1.1 Product Overview and Scope of Endoscopic Retrograde Cholangiopancreatography
1.2 Classification of Endoscopic Retrograde Cholangiopancreatography by Types
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue Comparison by Types (2017-2023)
1.2.2 Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Types in 2017
1.2.3 Endoscopic sphincterotomy
1.2.4 Removal of stones or other biliary debris
1.2.5 Insertion of bile duct stent(s)
1.2.6 Dilation of strictures
1.3 Global Endoscopic Retrograde Cholangiopancreatography Market by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Endoscopic Retrograde Cholangiopancreatography Market by Regions
1.4.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endoscopic Retrograde Cholangiopancreatography Status and Prospect (2013-2023)
1.5 Global Market Size of Endoscopic Retrograde Cholangiopancreatography (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.4 CONMED
2.4.1 Business Overview
2.4.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CONMED Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.5 Stryker
2.5.1 Business Overview
2.5.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Stryker Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.6 Fujifilm
2.6.1 Business Overview
2.6.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fujifilm Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ethicon
2.7.1 Business Overview
2.7.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ethicon Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.8 Becton Dickinson
2.8.1 Business Overview
2.8.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Becton Dickinson Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.9 B.Braun Melsungen
2.9.1 Business Overview
2.9.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 B.Braun Melsungen Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cook Group
2.10.1 Business Overview
2.10.2 Endoscopic Retrograde Cholangiopancreatography Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cook Group Endoscopic Retrograde Cholangiopancreatography Revenue, Gross Margin and Market Share (2016-2017)
3 Global Endoscopic Retrograde Cholangiopancreatography Market Competition, by Players
3.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Endoscopic Retrograde Cholangiopancreatography Players Market Share
3.2.2 Top 10 Endoscopic Retrograde Cholangiopancreatography Players Market Share
3.3 Market Competition Trend
4 Global Endoscopic Retrograde Cholangiopancreatography Market Size by Regions
4.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Market Share by Regions
4.2 North America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
4.3 Europe Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
4.5 South America Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
5 North America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
5.1 North America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2013-2018)
5.2 USA Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
5.3 Canada Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
5.4 Mexico Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
6 Europe Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
6.1 Europe Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2013-2018)
6.2 Germany Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
6.3 UK Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
6.4 France Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
6.5 Russia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
6.6 Italy Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
7.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2013-2018)
7.2 China Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
7.3 Japan Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
7.4 Korea Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
7.5 India Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
8 South America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries
8.1 South America Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2013-2018)
8.2 Brazil Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
8.3 Argentina Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
8.4 Colombia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Endoscopic Retrograde Cholangiopancreatography by Countries
9.1 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue by Countries (2013-2018)
9.2 Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
9.3 UAE Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
9.4 Egypt Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
9.5 Nigeria Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
9.6 South Africa Endoscopic Retrograde Cholangiopancreatography Revenue and Growth Rate (2013-2018)
10 Global Endoscopic Retrograde Cholangiopancreatography Market Segment by Type
10.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue and Market Share by Type (2013-2018)
10.2 Global Endoscopic Retrograde Cholangiopancreatography Market Forecast by Type (2018-2023)
10.3 Endoscopic sphincterotomy Revenue Growth Rate (2013-2023)
10.4 Removal of stones or other biliary debris Revenue Growth Rate (2013-2023)
10.5 Insertion of bile duct stent(s) Revenue Growth Rate (2013-2023)
10.6 Dilation of strictures Revenue Growth Rate (2013-2023)
11 Global Endoscopic Retrograde Cholangiopancreatography Market Segment by Application
11.1 Global Endoscopic Retrograde Cholangiopancreatography Revenue Market Share by Application (2013-2018)
11.2 Endoscopic Retrograde Cholangiopancreatography Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Endoscopic Retrograde Cholangiopancreatography Market Size Forecast (2018-2023)
12.1 Global Endoscopic Retrograde Cholangiopancreatography Market Size Forecast (2018-2023)
12.2 Global Endoscopic Retrograde Cholangiopancreatography Market Forecast by Regions (2018-2023)
12.3 North America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2018-2023)
12.4 Europe Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2018-2023)
12.6 South America Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Endoscopic Retrograde Cholangiopancreatography Picture
Table Product Specifications of Endoscopic Retrograde Cholangiopancreatography
Table Global Endoscopic Retrogr